Tracking Down Duodenopancreatic Malignancy by Samel-Westerhof, Constanze et al.
HPB Surgery, 2000, Vol. 00, pp. 405-411
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 2000 OPA (Overseas Publishers Association) N.V.
Published by license under
the Harwood Academic Publishers imprint,
part of The Gordon and Breach Publishing Group.
Printed in Malaysia.
Case Report
Tracking Down Duodenopancreatic Malignancy
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Background Malignant tumours of the duodenum
are rare and often difficult to diagnose. Due to the
small clinical experience with duodenal malignan-
cies their prognosis is unknown and resection is the
treatment of choice.
Case report Adding to a small series of incidental
tumours, we report the case of a 65-year-old patient
with primary extranodal (MALT-) lymphoma of the
duodenum infiltrating the pancreatic head. The
patient was admitted because of anaemia and
epigastric discomfort with a history of Helicobac-
ter-pylori associated gastric ulceration. Physical
examination and bloodchemical values were other-
wise normal. Endoscopy revealed duodenal ulcera-
tion but the biopsies taken from the ulceration did
not give any evidence of malignancy or residual
Helicobacter pylori infection. But MRT showed a
circular intramural tumour of the duodenum. On
laparotomy a large duodenal tumour adherent to the
pancreatic head was found and a Whipple procedure
was performed.
Conclusion Apart from describing the case of a
rare lymphoproliferative disorder of the duodenum,
this report illustrates the diagnostic difficulties with
uncommon neoplasm’s of the duodenopancreatic
region and the value of MRT prior to resection of a
duodenopancreatic mass.
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INTRODUCTION
Malignant neoplasm’s of the small bowel are
rare and their prognosis is vague [1]. A recent
epidemiological, US-American study [2] found
an average annual incidence rate of 9.9 per
million people for malignant tumours of the
small intestines. The incidence was higher
among men than among women and was found
to be overall rising and rising with age. The
most common histologic subtypes in this study
were carcinoid tumours (3.8/million) and adeno-
carcinoma (3.7/million), sarcoma (1.3/million)
and lymphoma (1.1/million). Smaller series have
seen adenocarcinoma [3] or lymphoma [4]
ahead in incidence. Adenocarcinoma seems to
be more common in industrialised countries,
where intestinal lymphomas are rather rare [5].
Intestinal lymphomas form a heterogeneous
subgroup of malignant lymphomas currently
classified in the Kiel-, or most recently in the
Revised European-American Classification of Lym-
phoid Neoplasm’s (=REAL) [6]. Intestinal B-Cell
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lymphoma, most often large cell lymphoma
[7], is common in the ileum [5] but rare in
the duodenum and may mimic adenocarcinoma
of the pancreatic head or duodenum or other
neoplasm’s of the duodenopancreatic region
[81.
Diagnosis of tumours of the duodenopancrea-
tic region, as it has been experienced by various
authors, is often obscured by vague abdominal
symptoms e.g., abdominal discomfort, nausea,
vomiting or weight loss. Physical examination
may reveal a palpable mass in patients with ad-
vanced tumour growth.
Endoscopic diagnosis of duodenal lesions
often fails because of a cryptic tumour site or
an essentially submucosal or intramural tumour
growth as in the presented case [9-11]. Brush
cytology may be of value in tumours of the
papilla of Vater but often is not conclusive when
taken from other sites [12]. Biopsy specimens,
too, may fail to verify a histologic diagnosis due
to endoscopically not accessible tumour sites.
Laboratory examinations and contrast enhanced
radiographs often lack characteristic findings
as well.
Modern techniques of all-in-one MRT, MRCP
and MRA may help to specify the diagnosis of
tumours of the duodenopancreatic region [13]
and to determine resectability [14]. Sensitivity of
MRT is high but specificity varies with tumour
site.
The case history, presented below, illustrates
some of these diagnostic difficulties of charac-
terising malignant tumours of the duodenopan-
creatic region and emphasises the value of
high-quality MRT.
CASE REPORT
A 65-year-old man was admitted because of
anaemia, loss of weight, fatigue and epigastric
discomfort with a suspected tumour of the
duodenopancreatic region. CT of the abdomen,
obtained prior to admission, had shown a mass
in the duodenopancreatic region, suspicious for
pancreatic adenocarcinoma.
On admission the patient was pale with a
haemoglobin of 8.4 g/dl. Bloodchemical values,
including serum electrophoresis, immune elec-
trophoresis, differential blood count, and physi-
cal examination were normal.
The patient had a history of gastric ulceration
and had received eradication for Helicobacter
pylori infection one year prior to admission. He
was under Phenobarbital medication for post-
traumatic epilepsy but had not had seizures for
10 years. He denied recent fever, loss of weight,
nausea or vomiting, jaundice, changes in bowel
habits or quality of stool and any other major
diseases. He had been operated for bilateral
inguinal hernia but did not have other abdomi-
nal surgery.
On gastroduodenal endoscopy the gastroduo-
denal passage appeared to be normal. An ulcer
was found in the descending duodenum proxi-
mal of the papilla. Mucosal biopsies from this
site showed signs of chronic inflammatory ul-
ceration without Helicobacter pylori infection.
An endoscopic retrograde choledochopancreatogra-
phy was performed demonstrating a regular
shape of bileduct and main pancreatic duct.
Contrary to the endoscopic findings, hypotonic
duodenography demonstrated subtotal stenosis of
the descending duodenum (Fig. 1).
MRT and MRCP were performed to further
characterise the suspected tumour. MRT (Fig. 2)
demonstrated a segmental circular wall thicken-
ing limited to the descending duodenum. A
submucosal tumour, e.g., lymphoma seemed to
be the most likely diagnosis. The pancreatic
head was normal in size. MRCP showed an
unremarkable main pancreatic duct, excluding a
pancreatic mass (Fig. 3).
Endoscopy was repeated and biopsies were
taken from around the papilla of Vater. Histo-
pathology of these biopsies again did not reveal
any conclusive malignant findings.
On laparotomy a large duodenal tumour of
circular intramural growth was found withoutFIGURE Hypotonic duodeno-radiography demonstrates a segmental stenosis of the descending duodenum.
FIGURE 2 Longitudinal MRT scan of the upper abdomen showing a segmental circular wall thickening limited to the
descending duodenum. The pancreatic head is normal in size.408 C. SAMEL-WESTERHOF et al.
FIGURE 3 MRCP demonstrates an unremarkable main pancreatic duct, excluding a pancreatic mass.
apparent infiltration of mucosa or serosa. The The diffuse lymphoid infiltrates contained a
tumour, however, was found to infiltrate the large population of CD-20 positive cells. CD-3
papilla of Vater and the pancreatic head. Sus- positive small T-cells were present in smaller
pecting malignancy a Whipple procedure was numbers and were dispersed in the B-cell pro-
performed. The macroscopic inspection of the liferates. Ki67-index was low and -lightchains
specimen revealed a semicircular infiltrative were restricted (Fig. 5b) in favour of &- light-
mass in the duodenal wall (Fig. 4). The patient chains (Fig. 5c). These findings are conclusive
recovered well and was discharged 10 days after of a low grade B-cell lymphoma according to
surgery. Adjuvant radiotherapy was performed the Kiel-classification scheme. The infiltration
starting four weeks after surgery, of lymphoid cells with lymphofollicular hyper-
Microscopic findings The tumorous mass plasia in the duodenal mucosa next to the
measured 5cm in longitudinal length and was mucosal ulceration, which merges with the
located in the wall of the duodenum. The duo- blastomatous infiltration of low grade B-cell
denal mucosa overlying the mass showed flat lymphoma in the underlying deeper zones of
ulceration. Microscopically there was a trans- the duodenal wall, is highly suggestive of a B-
mural infiltration of the entire thickness of the cell lymphoma derived from mucosa-associated
duodenal wall by proliferating lymphoid cell. lymphoid tissue (=MALT) of the duodenum.
These cells infiltrated the serosa and the pan- Helicobacter pylori, however, was not evident
creatic parenchyma also (Fig. 5a). The papilla neither in the tumour specimen nor in the
of Vater was free of blastomatous infiltrates, gastroduodenal biopsies taken preoperatively.DUODENOPANCREATIC LYMPHOMA 409
FIGURE 4 Gross photograph of the duodenum with a segmental intramural tumour of circular growth. The papilla of Vater is
indicated by a probe.
DISCUSSION
Reconsidering this case history, several ques-
tions arise: Could preoperative diagnosis been
more effective, has surgery been necessary for
this type of neoplastic lesion of duodenum and
pancreas, and do primary (extranodal) duode-
nopancreatic lymphomas belong to the group of
gastric lymphomas rather than to the group of
intestinal lymphomas?
The few documented cases of primary
(=extranodal) duodenal lymphoma reflect the
variety of histologic subtypes of B-cell-lym-
phoma [15-17]. Lymphomas of the papilla of
Vater may form another subgroup of intestinal
B-cell-lymphoma [18-20]. Lymphoma of the
stomach is known to occur in the setting of
chronic Helicobacter pylori gastritis. Gastric
lymphomas, located in the distal stomach,
may invade the duodenum [21] and may mimic
primary duodenal tumours there. In the pre-
sented case, duodenal ulceration and a history
of Helicobacter pylori induced gastric ulcer-
ation may have been associated with the410 C. SAMEL-WESTERHOF et al.
FIGURE 5 A photomicrograph of a low-power field of the tumour shows a diffuse proliferation of lymphoid cells with
infiltration of the pancreatic parenchyma (left field). Medium-power fields of this lymphoma, immunostained for -lightchains
(right .upper field: negative) and for &-lightchains (right lower field: positive in B-cells with lymphoplasmocytoid
differentiation) showing a lightchain restriction as an evidence for a neoplastic proliferation.
pathogenesis of duodenal lymphoma. It has
to remain unclear, however, whether the re-
ported MALT-lymphoma represents a gastric
lesion, which had skipped into the duodenum
or a primary tumour.
Only little experience with the heterogeneous
group of small bowel B-cell lymphomas has
been gathered so far and treatment recommen-
dations are still a matter of debate [22]. Several
studies are currently on their way to compare
radiotherapy, chemotherapy, surgery and multi-
modal approaches. There is only minor evidence
[23], that eradication of Helicobacter pylori is
beneficial in other than gastric lymphoma. Re-
section still is the predominant treatment for
duodenopancreatic lymphoma [24, 25] as for any
duodenopancreatic tumour of suspected malig-
nancy, due to the lack of clinical data on medical
treatment options, and, of course due to the
difficulties of finding a preoperative diagnosis
as well. It is another "dilemma" for surgeons
[26] that the decision whether to resect or not
to resect such a tumour often has to be made
without a definite histopathologic diagnosis.
In the presented case, a tumour of the duo-
denopancreatic region was suspected but no
histologic findings were obtained in the course
of diagnostic procedures. Only MRT properly
identified an intramural duodenal tumour.
But experience in viewing such tumours still
is too limited as to provide a specific char-
acterisation of rare lesions. In such cases itDUODENOPANCREATIC LYMPHOMA 411
will be left to the surgeon to decide, whether to
resect a duodenopancreatic tumour of unknown
histology or not.
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